US2002146719A1PendingUtilityA1
Human narcolepsy gene
Est. expiryAug 23, 2019(expired)· nominal 20-yr term from priority
C12Q 2600/118C12Q 1/6883C07K 14/70571A61K 48/00C12Q 2600/156
46
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The gene for hypocretin (orexin) receptor 1 (HCRTR1), which is associated with narcolepsy, is disclosed. Also described are methods of diagnosis of narcolepsy, pharmaceutical compositions comprising nucleic acids comprising the HCRTR1 gene, as well as methods of therapy of narcolepsy.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of diagnosing narcolepsy in an individual, comprising detecting a mutation in the gene encoding hypocretin (orexin) receptor 1, wherein the presence of the mutation in the gene is indicative of narcolepsy.
2 . A pharmaceutical composition comprising a nucleic acid comprising the isolated nucleic acid molecule of SEQ ID NO:1.
3 . A method of treating narcolepsy in an individual, comprising administering to the individual an isolated nucleic acid of SEQ ID NO:1 in a therapeutically effective amount.Join the waitlist — get patent alerts
Track US2002146719A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.